指南与共识糖尿病

一般人群胰岛自身抗体筛查早期1型糖尿病国际共识

International consensus guidance for general population screening for islet autoantibodies to diagnose early-stage type 1 diabetes: a nominal group technique process.
指南 / 共识 · Diabetologia · 2026-09-10

该国际共识采用名义小组技术制定,针对一般人群通过检测胰岛自身抗体(IAbs)以诊断早期1型糖尿病提供实施原则与实践指导。共识指出早期识别可预防糖尿病酮症酸中毒(DKA)、实现门诊及时启动胰岛素并改善长期血糖管理,同时明确了建立有效筛查项目的最低要求。

要点

  • 一般人群筛查IAbs可识别早期1型糖尿病,预防DKA并减轻临床起病。
  • 早期诊断有助于门诊及时启用胰岛素并改善长期血糖管理。
  • 共识提出建立有效人群筛查项目的最低要求。

核心结论

  • 通过一般人群筛查胰岛自身抗体可早期诊断1型糖尿病,预防DKA并带来更轻的临床起病。

研究设计与样本

  • 国际共识,采用名义小组技术制定,并获得多个专业协会认可。

主要发现

  • 1型糖尿病临床诊断时,20%至67%的儿童和青少年因DKA需住院,其中三分之一需重症监护。
  • 早期识别联合疾病进展监测与教育可预防DKA,并使临床起病更轻。
  • 早期诊断可实现门诊及时启动胰岛素并改善长期血糖管理。
  • 早期诊断还可获得可延迟临床起病的新型疾病修饰疗法。

临床怎么用

  • 在一般人群中实施IAbs筛查以诊断早期1型糖尿病,并遵循共识提出的原则与实践指导。
  • 建立有效筛查项目需满足共识列出的最低要求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Type 1 diabetes is an autoimmune disease that targets and destroys insulin-producing beta cells in the pancreatic islets. The incidence of type 1 diabetes is rising globally. At the clinical diagnosis of type 1 diabetes, between 20% and 67% of children and adolescents present with diabetic ketoacidosis (DKA) requiring hospitalisation, and one-third of these require intensive care. Type 1 diabetes can be detected in early stages, prior to the insulin-requiring clinical diagnosis, through screening for islet autoantibodies (IAbs). Identifying individuals with early-stage type 1 diabetes, combined with monitoring of and education on disease progression, prevents DKA and results in a milder clinical onset. This allows for timely insulin initiation in outpatient settings and improved long-term glucose management. Early diagnosis also enables access to novel disease-modifying therapies that can delay the clinical onset of diabetes. In this international consensus, we provide guidance on the principles and practice of implementing general population screening for IAbs to diagnose early-stage type 1 diabetes. We also outline the minimum requirements for establishing effective population screening programmes to diagnose early-stage type 1 diabetes through IAb detection. This consensus statement has been endorsed by the following professional associations: Advanced Technologies & Treatments for Diabetes (ATTD); Association of Diabetes Care and Education Specialists (ADCES); Association Belge Du Diabète; Associazione Medici Diabetologi (AMD); Australian Diabetes Society (ADS); Belgian Diabetes Liga; Breakthrough T1D; Czech Diabetes Society (ČDS); EASD; Finnish Diabetes Association (FDS); Fondazione Italiana Diabete (FID); International Diabetes Federation (IDF)-Europe; International Society of Paediatric and Adolescent Diabetes (ISPAD); Paediatric Endocrinology Nursing Society (PENS); Polish Diabetes Society; Portuguese Diabetes Association (APDP); Sociedade Portuguesa de Diabetologia (SPD); Società Italiana di Diabetologia (SID); Société Francophone du Diabète (SFD) and Type 1 Diabetes Exchange (T1D Exchange).

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Ziegler AG, Rewers MJ, Achenbach P, et al. International consensus guidance for general population screening for islet autoantibodies to diagnose early-stage type 1 diabetes: a nominal group technique process. Diabetologia. 2026. PMID: 42720753. doi:10.1007/s00125-026-06841-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。